Project

Fenix Therapeutics

Fenix Therapeutics aims to reshape cancer outcomes, providing hope to patients by transforming the future of oncology through more specific and effective treatments.

Fenix Therapeutics aims to reshape cancer outcomes, providing hope to patients by transforming the future of oncology through more specific and effective treatments. Our interdisciplinary team of accomplished cancer biologists, oncologists, and chemists ensures the innovative success of our approach. Together, we can transform the landscape of cancer treatment and positively impact the lives of many cancer patients and their families.

Project team

Project leader: Prof Marc Vooijs (UM), Member: Thijs van den Munckhof

Project Number

BIOB24062

Year granted

2024

Status

Ongoing

Applicant

Maastricht University

Funding

€ 200.000

Sector/Industry

Health & Pharma

SDG's

Thematic Cluster

TC5: Vaccines, Small Molecules, Discovery & Development Platforms

Level

Level 1
Molecuul

2024

Year granted

Maastricht University

Applicant

€ 200.000

Project funded
IBB

Meet the Industrial Biotech Bootcamp 2026 cohort

The selection process is complete, and we are excited to introduce the teams selected for the 2026 Industrial Biotech Bootcamp

Meet the Industrial Biotech Bootcamp 2026 cohort
Alumni Column

Alumni Column: Pim Schaasberg from ProteoT

Finished, but not yet done. That sounds like a contradiction. But for Pim Schaasberg, CEO of ProteoT, it is exactly

Alumni Column: Pim Schaasberg from ProteoT
Project story

The tRNA experts 

With his project tRNA for CMT, Erik and his team are currently part of the Biotech Booster program and are

The tRNA experts 
Impact developer portrait

The Innovation Journey at a University of Applied Sciences

Biotech Booster connects Business Developers and the newly introduced Impact Developers to the broader ecosystem. While both roles focus on

The Innovation Journey at a University of Applied Sciences
Project story

Tulip Enzyme Solutions: smarter enzymes, built together

The Biotech Booster team spoke with Allison Wolder, co-founder of Tulip Enzyme Solutions, a Biotech Booster project that joined the

Tulip Enzyme Solutions: smarter enzymes, built together
Project story

Biotech Ideas Out of the Lab, Fast Into Real-world Execution 

“Humans create a lot of waste. We are the only species in the world that create so much persistent waste

Biotech Ideas Out of the Lab, Fast Into Real-world Execution 
Citaat

Biotech Booster helps us through funding and by providing us with a network to validate where we can make the best impact with our new analysis device.

Biotechnology netherlands

Carlos de Lannoy

Constellate

Citaat

What we look forward to most is leveraging the extraordinary network of Biotech Booster that we need to get foot in the market, get know-how, and understanding the competitive field which is necessary for setting up successful operations.

Biotechnology netherlands

Pim Schaasberg & Martin Pabst

ProteoT

Moleculen

Newsletter

Receive monthly updates about our community!

Subscribe to our newsletter